| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 | Mar, 2021 |
| Sales | 381 | 184 | 364 | 171 | 259 |
| Sales Growth | +106.88% | -49.34% | +112.23% | -33.70% | +730.75% |
| Net Income | -8,265 | -7,446 | -25,364 | -10,258 | -617 |
| Net Income Growth | -10.99% | +70.64% | -147.25% | -1,561.30% | +86.67% |
Burcon Nutrascience Corporation (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Burcon NutraScience Corp is a technology company in the development of plant-based proteins. With several issued patent applications, that have been developed, Burcon has grown a portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed, and more. Its joint venture Merit Foods is building a protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients.
Fiscal Year End Date: 03/31